Novartis and Malaria No More help fulfill malaria treatment goal in Zambia by raising funds for three million treatments through Power of One

.One million antimalarial treatments donated by Novartis, matching one million treatments funded through Malaria No More’s Power of One campaign

.Since 2009, Novartis has delivered over 600 million treatments without profit to malaria-endemic countries

.Today marks World Health Day, focusing on vector-borne diseases, of which malaria is the most deadly (1)

Novartis (NVS) (http://www.novartis.com) announced today that two million treatments of its pediatric antimalarial are arriving in...

Dr. Linus Igwemezie, Head of the Novartis Malaria Initiative.

WHO prequalified Coartem® 80/480mg is the first and only  high strength malaria treatment available for donor-funded public sector procurement

*WHO prequalified Coartem® 80/480mg is the first and only  high strength malaria treatment available for donor-funded public sector procurement

*Coartem® 80/480mg reduces the pill burden for patients, potentially improving adherence to treatment and clinical outcomes

*This follows the...

Dr. Linus Igwemezie, Head of the Novartis Malaria Initiative.

 *Malaria experts and leaders from over 35 African countries gather to explore innovative strategies to move from malaria control to elimination

*Meeting convened by Novartis fosters best practice sharing and helps catalyze action to achieve new WHO objective of 90% reduction in malaria burden by 2030

*Growing threats including inadequate funding, first signs of drug resistance, and the advance of diseases such as Ebola, could...

Global Fund to reclaim lost malaria funds  The Citizen Daily

Nearly 700 million cases of malaria have been prevented in Africa as a result of concerted efforts to tackle the disease since 2000, say researchers.

Organised jointly by the Tanzanian Training Centre for International Health, Ifakara, Tanzania, and the Swiss Tropical and Public Health Institute with the financial support of the Impact malaria, a Sanofi Access to Medicines program and the Swiss Agency for Development and Cooperation, the Malaria course is a tutorial that is aimed at strengthening competence of researchers, public health personnel and care givers to fight Malaria in Africa. Participants are taught how to conduct...

Pharmaceutical firm to donate two million tablets of malaria drug to world's largest COVID-19 trial  Daily MailScientists search for effective COVID-19 treatments  Al Jazeera EnglishWhat do you have to lose taking hydroxychloroquine for coronavirus? Potentially your life.  USA TODAYCoronavirus: Clinical trial of hydroxychloroquine for COVID-19 treatment begins in US  Gulf NewsTrump’s chloroquine hype is a misinformation problem bigger than social media  The VergeView Full coverage on Google...

World Malaria Day 2015:Invest in the Future, Defeat Malaria
The World Malaria Day theme provides a common platform for all malaria partners to showcase their successes in malaria control and unify diverse initiatives in the changing global context. Malaria-endemic countries have made incredible gains in malaria in the last decade, but sustaining them will take extra efforts until the job is finished and malaria is eliminated worldwide. The theme for 2015 is Invest in the future, Defeat...